CN Stock MarketDetailed Quotes

301211 Hubei Biocause Heilen Pharmaceutical

Watchlist
  • 19.83
  • +1.08+5.76%
Market Closed Dec 20 15:00 CST
5.71BMarket Cap53.74P/E (TTM)

Hubei Biocause Heilen Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-69.89%520.75M
-40.89%1.02B
-8.91%1.66B
-8.81%1.69B
-8.47%1.73B
-10.97%1.73B
-4.53%1.83B
-0.08%1.86B
594.02%1.89B
954.52%1.94B
Transactional financial assets
774.79%1.1B
377.00%598.07M
14.75%119.31M
24.45%129.4M
--125.38M
--125.38M
--103.98M
--103.98M
----
----
Notes receivable and accounts receivable
-4.07%70.4M
-19.33%76.53M
19.89%84.99M
-5.16%67.97M
1.62%73.39M
6.86%94.87M
-31.82%70.89M
-45.16%71.68M
-48.48%72.22M
-28.57%88.78M
-Notes receivable
--5.12M
--5.74M
--14.67M
--15.53M
----
----
----
----
----
----
-Accounts receivable
-11.05%65.28M
-25.38%70.79M
-0.81%70.32M
-26.83%52.44M
1.62%73.39M
6.86%94.87M
-31.82%70.89M
-45.16%71.68M
-48.48%72.22M
-28.57%88.78M
Other receivables (including interest and dividends)
-25.69%8.7M
-60.63%4.37M
-54.57%5.23M
46.40%4.48M
2.73%11.7M
48.55%11.09M
68.65%11.52M
-59.53%3.06M
31.09%11.39M
4.83%7.47M
-Other receivable
----
-60.63%4.37M
----
----
----
48.55%11.09M
----
-59.53%3.06M
----
4.83%7.47M
Advance payment
-18.81%13.24M
-67.58%8.3M
-76.07%8.23M
-33.32%12.26M
1.12%16.3M
156.56%25.61M
94.71%34.39M
315.00%18.39M
226.08%16.12M
60.51%9.98M
Inventories
16.81%155.09M
44.64%180.16M
37.34%167.61M
51.53%173.8M
36.97%132.77M
7.50%124.56M
34.23%122.05M
28.16%114.7M
1.28%96.94M
4.20%115.87M
Receivable financing
-90.15%2.69M
-89.40%2.98M
-71.07%8.22M
-87.27%7.1M
197.43%27.33M
93.65%28.08M
-6.34%28.4M
83.93%55.8M
-75.35%9.19M
-8.82%14.5M
Other current assets
214.83%9.16M
174.68%7.97M
427.27%6.02M
696.88%9.6M
1,475.22%2.91M
45.96%2.9M
51.00%1.14M
-82.85%1.2M
-93.57%184.7K
56.60%1.99M
Total current assets
-11.44%1.88B
-11.28%1.9B
-6.16%2.06B
-5.75%2.1B
1.13%2.12B
-1.80%2.14B
1.63%2.2B
4.59%2.23B
198.40%2.1B
230.18%2.18B
Non Current assets
Other equity investment
--10M
--10M
----
----
----
----
----
----
----
----
Fixed assets
----
3.15%123.48M
----
----
----
-5.77%119.71M
----
-2.49%126.31M
----
-3.83%127.04M
Constru in process
----
257.96%312.05M
----
----
----
1,970.04%87.18M
----
2,266.59%51.44M
----
1,532.60%4.21M
Construction materials
----
----
----
----
----
--25.72M
----
--119.48K
----
----
Intangible assets
-3.00%69.46M
-2.97%70.02M
-2.98%70.58M
-3.01%71.07M
-2.75%71.6M
9.85%72.16M
9.92%72.75M
9.91%73.27M
9.65%73.63M
8.49%65.69M
Long deferred expense
-34.17%1.12M
2.65%1.19M
193.57%1.26M
--1.33M
--1.7M
--1.16M
--429.82K
----
----
----
Deferred tax assets
71.59%2.19M
71.59%2.19M
71.59%2.19M
-8.12%2.19M
-16.09%1.28M
-16.09%1.28M
-16.09%1.28M
56.70%2.39M
-1.44%1.52M
1.98%1.52M
Usufruct assets
-22.18%4.59M
-20.95%4.93M
-19.86%5.28M
-18.86%5.63M
--5.89M
--6.24M
--6.59M
--6.94M
----
----
Other non current assets
-90.43%2.67M
-89.21%3.93M
-49.97%7.99M
-3.81%11.03M
1,519.92%27.86M
2,015.19%36.38M
1,188.82%15.98M
824.90%11.47M
--1.72M
-74.72%1.72M
Total non current assets
47.55%560.24M
50.87%527.79M
69.64%479.55M
64.61%447.62M
74.39%379.7M
74.75%349.83M
42.54%282.68M
35.20%271.94M
7.51%217.73M
-0.51%200.19M
Total assets
-2.47%2.44B
-2.56%2.43B
2.48%2.54B
1.91%2.55B
8.03%2.5B
4.63%2.49B
5.07%2.48B
7.23%2.5B
155.67%2.31B
176.34%2.38B
Liabilities
Current liabilities
Notes payable and accounts payable
1.17%88.95M
-10.47%85.2M
52.39%91.73M
42.46%117.71M
231.21%87.92M
110.15%95.16M
53.82%60.19M
128.71%82.62M
-29.32%26.55M
12.29%45.28M
-Notes payable
----
----
--7.9M
--7.9M
--17M
--17M
----
----
----
----
-Accounts payable
25.42%88.95M
9.00%85.2M
39.27%83.83M
32.90%109.81M
167.17%70.92M
72.61%78.16M
53.82%60.19M
128.71%82.62M
-29.32%26.55M
12.29%45.28M
Contract liabilities
22.84%15.59M
-42.63%9.86M
-62.73%10.42M
-78.48%15.01M
17.76%12.69M
51.56%17.19M
165.83%27.97M
999.44%69.72M
156.10%10.78M
-1.64%11.34M
Salaries payable
39.48%10.06M
26.21%8.48M
28.12%7.24M
29.67%10.87M
-10.54%7.22M
16.73%6.72M
7.89%5.65M
37.95%8.38M
38.01%8.07M
12.67%5.76M
Taxs payable
-73.17%5.69M
-42.23%13.34M
-7.26%9.76M
-22.08%15.92M
24.72%21.23M
76.82%23.09M
-48.55%10.52M
41.28%20.43M
-9.73%17.02M
-1.09%13.06M
Other payable (including interest and dividends)
-87.47%1.84M
-85.37%3.25M
-79.92%4M
-47.43%3.03M
58.35%14.68M
74.29%22.22M
76.84%19.9M
-39.08%5.76M
13.60%9.27M
87.76%12.75M
-Other payable
----
-85.37%3.25M
----
----
----
74.29%22.22M
----
-39.08%5.76M
----
87.76%12.75M
Non current liabilities due within one year
197.81%1.51M
114.57%1.51M
44.48%1.51M
56.19%1.51M
--506.43K
--702.89K
--1.04M
--965.61K
----
----
Other current liabilities
-69.87%4.71M
-74.13%5.32M
-67.18%8.68M
-47.20%11.11M
104.72%15.63M
67.13%20.58M
37.52%26.45M
-31.16%21.03M
-70.20%7.63M
4.93%12.31M
Total current liabilities
-19.71%128.36M
-31.62%126.96M
-12.12%133.34M
-16.16%175.14M
101.57%159.87M
84.74%185.67M
43.38%151.74M
102.81%208.91M
-20.88%79.32M
13.31%100.5M
Current liabilities
Deferred tax liabilities
32.38%7.49M
32.38%7.49M
32.38%7.49M
11.83%7.49M
33.39%5.66M
33.39%5.66M
33.39%5.66M
57.91%6.7M
-4.59%4.24M
-8.87%4.24M
Long term deferred income
961.58%2.07M
918.65%2.08M
879.39%2.09M
843.35%2.1M
-22.93%195.03K
-22.13%204.14K
-21.38%213.26K
-20.69%222.37K
-14.19%253.04K
-15.27%262.15K
Lease liabilities
-42.21%3.72M
-36.81%4.06M
-31.47%4.41M
-19.84%5.15M
--6.43M
--6.43M
--6.43M
--6.43M
----
----
Total non current liabilities
8.09%13.28M
10.91%13.64M
13.69%13.99M
10.42%14.74M
173.27%12.29M
172.92%12.29M
172.57%12.3M
195.23%13.35M
-5.19%4.5M
-9.27%4.5M
Total liabilities
-17.73%141.64M
-28.98%140.6M
-10.19%147.33M
-14.57%189.89M
105.42%172.16M
88.52%197.96M
48.66%164.04M
106.70%222.26M
-20.17%83.81M
12.11%105.01M
Shareholders equity
Paid-in capital
0.00%288M
0.00%288M
20.00%288M
20.00%288M
20.00%288M
20.00%288M
0.00%240M
0.00%240M
33.33%240M
33.33%240M
Capital reserve funds
0.00%1.76B
0.00%1.76B
-2.66%1.76B
-2.66%1.76B
-2.66%1.76B
-2.66%1.76B
0.00%1.8B
0.00%1.8B
289.09%1.8B
289.09%1.8B
Surplus reserve funds
48.95%49.97M
48.95%49.97M
48.95%49.97M
48.95%49.97M
51.63%33.55M
51.63%33.55M
51.63%33.55M
51.63%33.55M
111.99%22.13M
111.99%22.13M
Retained profit
-19.57%198.62M
-10.68%192.46M
25.68%299.58M
32.09%262.2M
51.79%246.95M
2.35%215.48M
29.47%238.36M
27.14%198.51M
11.79%162.69M
84.40%210.54M
Specific reserves
35.90%2.32M
27.08%1.28M
167.77%869.44K
----
--1.71M
--1.01M
--324.69K
----
----
----
Shareholders equity without minority interests
-1.35%2.3B
-0.28%2.29B
3.37%2.39B
3.52%2.36B
4.37%2.33B
0.76%2.29B
2.93%2.32B
2.42%2.28B
178.75%2.23B
196.36%2.28B
Total shareholder equity
-1.35%2.3B
-0.28%2.29B
3.37%2.39B
3.52%2.36B
4.37%2.33B
0.76%2.29B
2.93%2.32B
2.42%2.28B
178.75%2.23B
196.36%2.28B
Total liabilityies and equity
-2.47%2.44B
-2.56%2.43B
2.48%2.54B
1.91%2.55B
8.03%2.5B
4.63%2.49B
5.07%2.48B
7.23%2.5B
155.67%2.31B
176.34%2.38B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -69.89%520.75M-40.89%1.02B-8.91%1.66B-8.81%1.69B-8.47%1.73B-10.97%1.73B-4.53%1.83B-0.08%1.86B594.02%1.89B954.52%1.94B
Transactional financial assets 774.79%1.1B377.00%598.07M14.75%119.31M24.45%129.4M--125.38M--125.38M--103.98M--103.98M--------
Notes receivable and accounts receivable -4.07%70.4M-19.33%76.53M19.89%84.99M-5.16%67.97M1.62%73.39M6.86%94.87M-31.82%70.89M-45.16%71.68M-48.48%72.22M-28.57%88.78M
-Notes receivable --5.12M--5.74M--14.67M--15.53M------------------------
-Accounts receivable -11.05%65.28M-25.38%70.79M-0.81%70.32M-26.83%52.44M1.62%73.39M6.86%94.87M-31.82%70.89M-45.16%71.68M-48.48%72.22M-28.57%88.78M
Other receivables (including interest and dividends) -25.69%8.7M-60.63%4.37M-54.57%5.23M46.40%4.48M2.73%11.7M48.55%11.09M68.65%11.52M-59.53%3.06M31.09%11.39M4.83%7.47M
-Other receivable -----60.63%4.37M------------48.55%11.09M-----59.53%3.06M----4.83%7.47M
Advance payment -18.81%13.24M-67.58%8.3M-76.07%8.23M-33.32%12.26M1.12%16.3M156.56%25.61M94.71%34.39M315.00%18.39M226.08%16.12M60.51%9.98M
Inventories 16.81%155.09M44.64%180.16M37.34%167.61M51.53%173.8M36.97%132.77M7.50%124.56M34.23%122.05M28.16%114.7M1.28%96.94M4.20%115.87M
Receivable financing -90.15%2.69M-89.40%2.98M-71.07%8.22M-87.27%7.1M197.43%27.33M93.65%28.08M-6.34%28.4M83.93%55.8M-75.35%9.19M-8.82%14.5M
Other current assets 214.83%9.16M174.68%7.97M427.27%6.02M696.88%9.6M1,475.22%2.91M45.96%2.9M51.00%1.14M-82.85%1.2M-93.57%184.7K56.60%1.99M
Total current assets -11.44%1.88B-11.28%1.9B-6.16%2.06B-5.75%2.1B1.13%2.12B-1.80%2.14B1.63%2.2B4.59%2.23B198.40%2.1B230.18%2.18B
Non Current assets
Other equity investment --10M--10M--------------------------------
Fixed assets ----3.15%123.48M-------------5.77%119.71M-----2.49%126.31M-----3.83%127.04M
Constru in process ----257.96%312.05M------------1,970.04%87.18M----2,266.59%51.44M----1,532.60%4.21M
Construction materials ----------------------25.72M------119.48K--------
Intangible assets -3.00%69.46M-2.97%70.02M-2.98%70.58M-3.01%71.07M-2.75%71.6M9.85%72.16M9.92%72.75M9.91%73.27M9.65%73.63M8.49%65.69M
Long deferred expense -34.17%1.12M2.65%1.19M193.57%1.26M--1.33M--1.7M--1.16M--429.82K------------
Deferred tax assets 71.59%2.19M71.59%2.19M71.59%2.19M-8.12%2.19M-16.09%1.28M-16.09%1.28M-16.09%1.28M56.70%2.39M-1.44%1.52M1.98%1.52M
Usufruct assets -22.18%4.59M-20.95%4.93M-19.86%5.28M-18.86%5.63M--5.89M--6.24M--6.59M--6.94M--------
Other non current assets -90.43%2.67M-89.21%3.93M-49.97%7.99M-3.81%11.03M1,519.92%27.86M2,015.19%36.38M1,188.82%15.98M824.90%11.47M--1.72M-74.72%1.72M
Total non current assets 47.55%560.24M50.87%527.79M69.64%479.55M64.61%447.62M74.39%379.7M74.75%349.83M42.54%282.68M35.20%271.94M7.51%217.73M-0.51%200.19M
Total assets -2.47%2.44B-2.56%2.43B2.48%2.54B1.91%2.55B8.03%2.5B4.63%2.49B5.07%2.48B7.23%2.5B155.67%2.31B176.34%2.38B
Liabilities
Current liabilities
Notes payable and accounts payable 1.17%88.95M-10.47%85.2M52.39%91.73M42.46%117.71M231.21%87.92M110.15%95.16M53.82%60.19M128.71%82.62M-29.32%26.55M12.29%45.28M
-Notes payable ----------7.9M--7.9M--17M--17M----------------
-Accounts payable 25.42%88.95M9.00%85.2M39.27%83.83M32.90%109.81M167.17%70.92M72.61%78.16M53.82%60.19M128.71%82.62M-29.32%26.55M12.29%45.28M
Contract liabilities 22.84%15.59M-42.63%9.86M-62.73%10.42M-78.48%15.01M17.76%12.69M51.56%17.19M165.83%27.97M999.44%69.72M156.10%10.78M-1.64%11.34M
Salaries payable 39.48%10.06M26.21%8.48M28.12%7.24M29.67%10.87M-10.54%7.22M16.73%6.72M7.89%5.65M37.95%8.38M38.01%8.07M12.67%5.76M
Taxs payable -73.17%5.69M-42.23%13.34M-7.26%9.76M-22.08%15.92M24.72%21.23M76.82%23.09M-48.55%10.52M41.28%20.43M-9.73%17.02M-1.09%13.06M
Other payable (including interest and dividends) -87.47%1.84M-85.37%3.25M-79.92%4M-47.43%3.03M58.35%14.68M74.29%22.22M76.84%19.9M-39.08%5.76M13.60%9.27M87.76%12.75M
-Other payable -----85.37%3.25M------------74.29%22.22M-----39.08%5.76M----87.76%12.75M
Non current liabilities due within one year 197.81%1.51M114.57%1.51M44.48%1.51M56.19%1.51M--506.43K--702.89K--1.04M--965.61K--------
Other current liabilities -69.87%4.71M-74.13%5.32M-67.18%8.68M-47.20%11.11M104.72%15.63M67.13%20.58M37.52%26.45M-31.16%21.03M-70.20%7.63M4.93%12.31M
Total current liabilities -19.71%128.36M-31.62%126.96M-12.12%133.34M-16.16%175.14M101.57%159.87M84.74%185.67M43.38%151.74M102.81%208.91M-20.88%79.32M13.31%100.5M
Current liabilities
Deferred tax liabilities 32.38%7.49M32.38%7.49M32.38%7.49M11.83%7.49M33.39%5.66M33.39%5.66M33.39%5.66M57.91%6.7M-4.59%4.24M-8.87%4.24M
Long term deferred income 961.58%2.07M918.65%2.08M879.39%2.09M843.35%2.1M-22.93%195.03K-22.13%204.14K-21.38%213.26K-20.69%222.37K-14.19%253.04K-15.27%262.15K
Lease liabilities -42.21%3.72M-36.81%4.06M-31.47%4.41M-19.84%5.15M--6.43M--6.43M--6.43M--6.43M--------
Total non current liabilities 8.09%13.28M10.91%13.64M13.69%13.99M10.42%14.74M173.27%12.29M172.92%12.29M172.57%12.3M195.23%13.35M-5.19%4.5M-9.27%4.5M
Total liabilities -17.73%141.64M-28.98%140.6M-10.19%147.33M-14.57%189.89M105.42%172.16M88.52%197.96M48.66%164.04M106.70%222.26M-20.17%83.81M12.11%105.01M
Shareholders equity
Paid-in capital 0.00%288M0.00%288M20.00%288M20.00%288M20.00%288M20.00%288M0.00%240M0.00%240M33.33%240M33.33%240M
Capital reserve funds 0.00%1.76B0.00%1.76B-2.66%1.76B-2.66%1.76B-2.66%1.76B-2.66%1.76B0.00%1.8B0.00%1.8B289.09%1.8B289.09%1.8B
Surplus reserve funds 48.95%49.97M48.95%49.97M48.95%49.97M48.95%49.97M51.63%33.55M51.63%33.55M51.63%33.55M51.63%33.55M111.99%22.13M111.99%22.13M
Retained profit -19.57%198.62M-10.68%192.46M25.68%299.58M32.09%262.2M51.79%246.95M2.35%215.48M29.47%238.36M27.14%198.51M11.79%162.69M84.40%210.54M
Specific reserves 35.90%2.32M27.08%1.28M167.77%869.44K------1.71M--1.01M--324.69K------------
Shareholders equity without minority interests -1.35%2.3B-0.28%2.29B3.37%2.39B3.52%2.36B4.37%2.33B0.76%2.29B2.93%2.32B2.42%2.28B178.75%2.23B196.36%2.28B
Total shareholder equity -1.35%2.3B-0.28%2.29B3.37%2.39B3.52%2.36B4.37%2.33B0.76%2.29B2.93%2.32B2.42%2.28B178.75%2.23B196.36%2.28B
Total liabilityies and equity -2.47%2.44B-2.56%2.43B2.48%2.54B1.91%2.55B8.03%2.5B4.63%2.49B5.07%2.48B7.23%2.5B155.67%2.31B176.34%2.38B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Daxin Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Virus Prevention
Virus Prevention
Intraday+0.60%